We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.93%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
+$256M
(+10%)
Cap. Flow
+$184M
Cap. Flow
% of AUM
6.78%
Top 10 Holdings %
Top 10 Hldgs %
6.67%
Holding
2,298
New
784
Increased
473
Reduced
488
Closed
552
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$19.5M |
| 2 |
Target
TGT
|
+$17.3M |
| 3 |
Royalty Pharma
RPRX
|
+$15.5M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$14.9M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.2M |
| 2 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$11M |
| 3 |
iShares Semiconductor ETF
SOXX
|
+$10.4M |
| 4 |
ProShares UltraPro Short QQQ
SQQQ
|
+$8.83M |
| 5 |
ProShares UltraPro S&P 500
UPRO
|
+$8.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.61% |
| 2 | Industrials | 13.75% |
| 3 | Healthcare | 12.7% |
| 4 | Consumer Discretionary | 12.54% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Burford Capital
BUR
$922M
| $876K | 0.03% |
+71,900
| New | +$930K |
|
752
Travere Therapeutics
TVTX
$5.33B
| $873K | 0.03% |
+56,858
| New | +$1.03M |
|
753
T-Mobile US
TMUS
$186B
| $871K | 0.03% |
6,274
+2,832
| +82% | +$397K |
|
754
Beam Therapeutics
BEAM
$2.73B
| $869K | 0.03% |
+27,225
| New | +$884K |
|
755
Baxter International
BAX
$13.8B
| $866K | 0.03% |
19,000
-185,414
| -91% | -$8.07M |
|
756
Eastman Chemical
EMN
$8.01B
| $861K | 0.03% |
10,289
+7,864
| +324% | +$639K |
|
757
PENN Entertainment
PENN
$2.75B
| $860K | 0.03% |
35,779
-126,913
| -78% | -$3.38M |
|
758
e.l.f. Beauty
ELF
$4.85B
| $857K | 0.03% |
7,506
-28,223
| -79% | -$2.72M |
|
759
Enanta Pharmaceuticals
ENTA
$378M
| $857K | 0.03% |
40,028
+24,060
| +151% | +$709K |
|
|
HBI
760
DELISTED
Hanesbrands
HBI
| $856K | 0.03% |
188,544
+164,456
| +683% | +$752K |
|
761
Oaktree Specialty Lending
OCSL
$1.03B
| $856K | 0.03% |
+44,042
| New | +$828K |
|
762
APi Group
APG
$17B
| $853K | 0.03% |
46,950
-72,909
| -61% | -$1.13M |
|
763
Supernus Pharmaceuticals
SUPN
$2.65B
| $851K | 0.03% |
+28,300
| New | +$990K |
|
764
DMC Global
BOOM
$129M
| $849K | 0.03% |
47,800
+32,000
| +203% | +$578K |
|
|
ACLX
765
DELISTED
Arcellx
ACLX
| $847K | 0.03% |
26,796
-3,355
| -11% | -$128K |
|
766
MaxLinear
MXL
$6.07B
| $847K | 0.03% |
26,834
+11,104
| +71% | +$321K |
|
|
AZUL
767
DELISTED
Azul
AZUL
| $845K | 0.03% |
61,743
+9,519
| +18% | +$86.6K |
|
768
Cheniere Energy
CQP
$31.5B
| $844K | 0.03% |
18,300
-18,630
| -50% | -$855K |
|
769
Agilent Technologies
A
$39.2B
| $843K | 0.03% |
7,012
-33,209
| -83% | -$4.23M |
|
770
Rayonier Advanced Materials
RYAM
$604M
| $842K | 0.03% |
196,845
+91,445
| +87% | +$433K |
|
|
SPWR
771
DELISTED
SunPower Corporation Common Stock
SPWR
| $842K | 0.03% |
85,898
+8,957
| +12% | +$105K |
|
|
P
772
Everpure Inc
P
$25B
| $839K | 0.03% |
+22,800
| New | +$646K |
|
773
Franklin Electric
FELE
$4.57B
| $839K | 0.03% |
8,149
+1,377
| +20% | +$129K |
|
774
Citigroup
C
$222B
| $837K | 0.03% |
+18,189
| New | +$852K |
|
775
Kinross Gold
KGC
$28B
| $837K | 0.03% |
175,500
-846,375
| -83% | -$4.23M |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q2 2023 Portfolio in Review
As of Q2 2023, Jump Financial held 2,298 positions worth $2.71B, up 10% from $2.46B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Jump Financial deployed $184M of net new capital in Q2 2023, opening 784 new positions and adding to 473 existing holdings. Its largest new stake was Royalty Pharma: 456,285 shares worth $14M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $12.2M trimmed.
- Jump Financial's largest Q2 2023 buy was Royalty Pharma: 456,285 shares worth $14M.
- Jump Financial added most to State Street Utilities Select Sector SPDR ETF in Q2 2023, an estimated $19.5M increase.
- Jump Financial's biggest Q2 2023 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $12.2M.
- Jump Financial fully exited ProShares Short VIX Short-Term Futures ETF in Q2 2023, selling an estimated $11M.
- Jump Financial's ten largest holdings make up 6.7% of its $2.71B portfolio in Q2 2023.
- Jump Financial opened 784 new positions and closed 552 in Q2 2023.
- Jump Financial's portfolio value rose 10% quarter-over-quarter to $2.71B.
Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.